Cargando…

The Effect of Nebivolol on Office Blood Pressure of Blacks Residing in Sub-Saharan Africa (A Pilot Study)

Introduction: There is substantial clinical evidence that monotherapy with beta-blockers are less effective in reducing blood pressure among hypertensive Black patients compared to Whites. The highly selective beta-1 agents like nebivolol and bisoprolol have, however, been reported to be effective i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ojji, Dike, Ale, Boni Maxime, Shedul, Lamkur, Umuerri, Ejiroghene, Ejim, Emmanuel, Alikor, Chizindu, Agunyenwa, Charles, Njideofor, Uche, Eze, Helen, Ansa, Victor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829216/ https://www.ncbi.nlm.nih.gov/pubmed/33505995 http://dx.doi.org/10.3389/fcvm.2020.613917

Ejemplares similares

Stakeholder perspectives on the demand and supply factors driving substandard and falsified blood pressure lowering medications in Nigeria: a qualitative study
por: Shedul, Grace, et al.
Publicado: (2022)

Primary care in the prevention, treatment and control of cardiovascular disease in sub-Saharan Africa
por: Ojji, Dike B, et al.
Publicado: (2017)

SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications
por: Ogah, Okechukwu S., et al.
Publicado: (2021)

A Comparative Study of Left Atrial Function Index of Hypertensive Heart Failure Patients Versus Controls in a Teaching Hospital, Sub-Saharan Africa
por: Kweki, Anthony G, et al.
Publicado: (2022)

Prevalence and correlates of prehypertension and hypertension among adults in Delta State, Nigeria: a cross-sectional community-based study
por: Umuerri, Ejiroghene M, et al.
Publicado: (2020)

Characteristics and Patterns of Retention in Hypertension Care in Primary Care Settings From the Hypertension Treatment in Nigeria Program
por: Ye, Jiancheng, et al.
Publicado: (2022)

Nephroblastoma with Right Atrial Extension
por: Umuerri, Ejiroghene Martha, et al.
Publicado: (2021)

Fixed‐dose combination therapy‐based protocol compared with free pill combination protocol: Results of a cluster randomized trial
por: Sanuade, Olutobi A., et al.
Publicado: (2023)

Hypertension Treatment in Nigeria (HTN) Program: rationale and design for a type 2 hybrid, effectiveness, and implementation interrupted time series trial
por: Baldridge, Abigail S., et al.
Publicado: (2022)

Nebivolol-induced gynecomastia
por: Köklü, Erkan, et al.
Publicado: (2015)

Sociodemographic predictors of non-communicable diseases risk-related knowledge and behaviours: a cross-sectional study of in-school adolescents in a southern Nigerian State
por: Oyibo, Patrick, et al.
Publicado: (2023)

(S,S,S,S)-Nebivolol hydrochloride hemihydrate
por: Rousselin, Yoann, et al.
Publicado: (2012)

Right Ventricular Systolic Dysfunction Is Common in Hypertensive Heart Failure: A Prospective Study in Sub-Saharan Africa
por: Ojji, Dike B., et al.
Publicado: (2016)

Clinical characteristics and treatment patterns of pregnant women with hypertension in primary care in the Federal Capital Territory of Nigeria: cross-sectional results from the hypertension treatment in Nigeria Program
por: Mahmoud, Zainab, et al.
Publicado: (2023)

Nebivolol in the treatment of chronic heart failure
por: Veverka, Angie, et al.
Publicado: (2007)

Influence of nebivolol on anticonvulsant effect of lamotrigine
por: Goel, Radha, et al.
Publicado: (2009)

Rhabdomyolysis in a patient taking nebivolol
por: Kim, Ye Jin, et al.
Publicado: (2016)

Association Between Electrocardiographic Left Atrial Enlargement and Echocardiographic Left Atrial Indices Among Hypertensive Subjects in a Tertiary Hospital in South South Nigeria
por: Aiwuyo, Henry O, et al.
Publicado: (2023)

Arterial stiffness, hypertension, and rational use of nebivolol
por: Agabiti-Rosei, Enrico, et al.
Publicado: (2009)

A Review of Nebivolol Pharmacology and Clinical Evidence
por: Fongemie, Justin, et al.
Publicado: (2015)

Nebivolol Ameliorates Nitric Oxide–Deficient Hypertension
por: Fortepiani, L.A., et al.
Publicado: (2002)

High prevalence of non-dipping patterns among Black Africans with uncontrolled hypertension: a secondary analysis of the CREOLE trial
por: Ingabire, Prossie Merab, et al.
Publicado: (2021)

Left ventricular mass estimation by different partition values in a large population of black hypertensive subjects
por: Ojji, Dike B., et al.
Publicado: (2018)

Nebivolol: impact on cardiac and endothelial function and clinical utility
por: Toblli, Jorge Eduardo, et al.
Publicado: (2012)

Formulation and Evaluation of S-(-)-Amlodipine Besylate and Nebivolol Hydrochloride Tablets
por: Shaikh, S.A, et al.
Publicado: (2010)

Development and In vitro Evaluation of Mucoadhesive Buccal Films of Nebivolol
por: Mane, P. P., et al.
Publicado: (2014)

Phenotypic differences in nebivolol metabolism and bioavailability in healthy volunteers
por: BRICIU, CORINA, et al.
Publicado: (2015)

Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer
por: Cochera, Flavia, et al.
Publicado: (2018)

Protective effect of nebivolol on doxorubicin-induced cardiotoxicity in rats
por: Mohamed, Enas Ahmed, et al.
Publicado: (2018)

Comparison of Nebivolol and Bisoprolol for Cardiovascular Mortality in Hypertensive Patients
por: Kumar, Ratan, et al.
Publicado: (2019)

Nitric oxide mediated the effects of nebivolol in cardiorenal syndrome
por: Mercanoglu, Guldem, et al.
Publicado: (2019)

Data of Nebivolol on oxidative stress parameters in hypertensive patients
por: Barroso, Helena C., et al.
Publicado: (2022)

Risk Assessment of Pre-dialysis Chronic Kidney Disease (CKD) Patients for Cardiovascular Disease (CVD) in a Tertiary Hospital in Nigeria: A Case-Controlled Cross-Sectional Study
por: Ovwasa, Henry, et al.
Publicado: (2023)

Prevalence and Predictors of Peripheral Vascular Disease Amongst Predialysis Hypertensive Chronic Kidney Disease Patients in Southern Nigeria
por: Ovwasa, Henry, et al.
Publicado: (2023)

A review of the safety and efficacy of nebivolol in the mildly hypertensive patient
por: John, Cockcroft
Publicado: (2007)

Simultaneous Estimation of Nebivolol Hydrochloride and Valsartan using RP HPLC
por: Kokil, S. U., et al.
Publicado: (2009)

Nebivolol: A unique drug in acute and chronic renal disorders
por: Amiri, Fateme Shamekhi
Publicado: (2015)

Hiding in Plain Sight: Nebivolol Exhibits Compelling Tocolytic Properties
por: Barnett, Scott D., et al.
Publicado: (2018)

Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model
por: Stücker, Sabrina, et al.
Publicado: (2017)

Protective effect of nebivolol on rat ovary exposed to deltamethrin toxicity
por: Otçu, Serap, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ugi3hb3s3vrct88h7j8asvjp5